THYROCARE — Thyrocare Technologies Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹45.67bn
- IN₹44.60bn
- IN₹5.72bn
- 98
- 15
- 97
- 85
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 777 | 1,177 | 1,388 | 1,401 | 1,461 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 173 | 514 | 953 | 894 | 468 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,523 | 2,381 | 2,700 | 2,729 | 2,785 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,726 | 1,601 | 1,868 | 1,944 | 2,037 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 4,693 | 5,458 | 6,077 | 6,327 | 6,439 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 817 | 951 | 645 | 771 | 905 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 1,027 | 1,185 | 811 | 984 | 1,171 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 3,667 | 4,273 | 5,266 | 5,343 | 5,268 |
Total Liabilities & Shareholders' Equity | 4,693 | 5,458 | 6,077 | 6,327 | 6,439 |
Total Common Shares Outstanding |